A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This is a study using sunitinib for patients ending treatment on a previous sunitinib malate
protocol to continue to receive sunitinib. The patient must have been enrolled in one of the
following studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108,
A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer
sponsored sunitinib studies may be included in the future.